Find uplifting stories about heroes, innovations, and solutions
13 results for "substance use disorder"
A Pennsylvania county is hosting a free community event featuring real recovery testimonials and launching new childcare services that help parents attend addiction treatment without choosing between their kids and getting help.
A groundbreaking VA study found that GLP-1 medications like Ozempic may reduce substance use disorders across alcohol, opioids, nicotine, and other drugs. For veterans battling addiction alongside diabetes, these findings could change everything.
Virginia Tech researchers created a way to measure recovery progress for people quitting multiple substances, celebrating each win instead of demanding complete abstinence. The study of 2,400 people shows incremental progress improves quality of life.
A medication designed for diabetes is unexpectedly quieting cravings for alcohol, nicotine, and other addictive substances, offering hope where few treatments exist. New research shows it could save thousands of lives each year.
Weight loss medications like Ozempic and Mounjaro are showing remarkable promise in fighting addiction to all major substances, from alcohol to opioids. A study of over 600,000 veterans reveals these drugs reduce substance use disorders by blocking the cravings that fuel addiction.
New research suggests GLP-1 medications may help treat alcohol, opioid, and drug addictions by quieting cravings in the brain. A study of 600,000 veterans found fewer ER visits and deaths across all substance types.
A groundbreaking study of 600,000 veterans shows GLP-1 medications like Ozempic dramatically reduce substance use disorders and cut drug-related deaths in half. The discovery could revolutionize how we treat addiction.
New research shows detox is only the beginning of addiction treatment, not the cure. Understanding addiction as a chronic brain condition is helping reshape recovery with more effective, long-term approaches.
Eye doctors at Mass General Brigham found a simple fix that saves lives: involving addiction specialists when treating patients with drug-related eye infections. The results? Every single patient who needed addiction medication received it.
University of Cincinnati researchers created an AI system that diagnoses substance use disorder with up to 83% accuracy, potentially speeding up treatment for millions. The low-cost technology could remove barriers to care and improve health equity.
University of Cincinnati researchers developed an AI that can predict substance use disorder with up to 83% accuracy using just a simple picture rating task on a smartphone. The breakthrough could help patients get treatment faster by overcoming the biggest barrier: denial and stigma.
The federal government just launched a $100 million initiative to connect people struggling with addiction and homelessness to treatment and recovery programs. The effort marks a major shift toward prevention and community-based care for millions of Americans battling substance use disorders.
A biotech company is launching with a groundbreaking mission: using GLP-1 medications to treat substance use disorders instead of weight loss. Baseline Therapeutics could open new hope for millions struggling with addiction.